Clinical, Genomic, and Pharmacological Study of <em>MYCN</em>-Amplified <em>RB1</em> Wild-Type Metastatic Retinoblastoma
An uncommon subgroup of unilateral retinoblastomas with highly aggressive histological features, lacking aberrations in <i>RB1</i> gene with high-level amplification of <i>MYCN</i> (<i>MCYN</i><inline-formula><math display="inline"><semant...
Main Authors: | Santiago Zugbi, Daiana Ganiewich, Arpita Bhattacharyya, Rosario Aschero, Daniela Ottaviani, Claudia Sampor, Eduardo G. Cafferata, Marcela Mena, Mariana Sgroi, Ursula Winter, Gabriela Lamas, Mariona Suñol, Manuel Daroqui, Edgardo Baialardo, Beatriz Salas, Anirban Das, Adriana Fandiño, Jasmine H. Francis, Fabiana Lubieniecki, Cinzia Lavarino, Ralph Garippa, Osvaldo L. Podhajcer, David H. Abramson, François Radvanyi, Guillermo Chantada, Andrea S. Llera, Paula Schaiquevich |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2714 |
Similar Items
-
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
by: Rosario Aschero, et al.
Published: (2021-02-01) -
<i>MYCN</i> Amplifications and Metabolic Rewiring in Neuroblastoma
by: Marialena Pouliou, et al.
Published: (2023-09-01) -
Extracellular Vesicle-Based Method for Detecting <i>MYCN</i> Amplification Status of Pediatric Neuroblastoma
by: Jirawan Panachan, et al.
Published: (2022-05-01) -
Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01) -
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> Amplification
by: Frank Berthold, et al.
Published: (2021-08-01)